NIH-funded research NIH-funded research

Understanding how arterial baroreceptors influence high blood pressure

Official title: Investigating Afferent Baroreflex Dysfunction in Hypertension

Funded at Louisiana State Univ Hsc Shreveport · NIH-11382286 · Data updated 2026-11-12

A research project is exploring whether nerves that sense blood pressure in the arteries help drive drug-resistant high blood pressure, using mouse models to study this neural pathway.

More Hypertension research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionLouisiana State Univ Hsc Shreveport
NIH-funded
Lab location1 site (Shreveport, United States)
Project startSeptember 1, 2025
Project endAugust 31, 2028
Funding year2026
Award (this year)$239,800
NIH project number5R00HL175100-04
Project IDNIH-11382286 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals with drug-resistant hypertension or patients who have advanced BP regulation issues and could benefit from future neural-targeted therapies.

Less likely to help

Patients whose hypertension is well-controlled by medications are less likely to directly benefit from this research.

What this research studies

This project focuses on how sensory nerves in the aortic arch contribute to high blood pressure, especially in cases where medicines fail. The researchers will use a mouse model with selective targeting of arterial baroreceptors to understand their role in BP regulation. Findings could uncover new ways to lower blood pressure by addressing neural signals rather than just drugs. The work combines anatomy, neural signaling, and physiology to map how baroreceptors influence BP homeostasis.

Why it matters

Potential benefit: If successful, the work could lead to novel targets for treating drug-resistant hypertension by modulating neural pathways that control blood pressure.

How similar studies have gone: Previous studies suggest baroreflex involvement in BP regulation, but selective targeting of arterial baroreceptors is a novel approach with uncertain outcomes.

Where this research is happening

  • Louisiana State Univ Hsc Shreveport
    Shreveport, United States
    Active

Researchers

  • Principal investigator: El Saafien, Khalid — Louisiana State Univ Hsc Shreveport
  • Study coordinator: El Saafien, Khalid

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.